Characterisation of methicillin-resistant Staphylococcus aureus with reduced susceptibility to teicoplanin in Eastern France.
Bertrand
X
X
Service d'Hygiène hospitalière et d'Epidémiologie moléculaire, CHU Jean Minjoz, 25030, Besançon, France. xbertrand@chu-besancon.fr
Hocquet
D
D
Thouverez
M
M
Plésiat
P
P
Talon
D
D
D017719:Diabetic Foot / Q000188:drug therapy* / Q000382:microbiology; D005500:Follow-Up Studies; D005602:France; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D018570:Risk Assessment; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D017334:Teicoplanin / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D017334:Teicoplanin